Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies

Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies Workshop Summary

Book (01 Jun 2015)

Save $5.32

  • RRP $42.17
  • $36.85
Add to basket

Includes delivery to the United States

1 copy available online - Usually dispatched within 7-10 days

Publisher's Synopsis

"One of the challenges in treating cancer is the disease's complexity and variation among patients. Cancer manifests differently in each patient, so treatments that are effective in one patient may not be effective in another. As cancer care becomes more personalized, subpopulations of individuals will be given preventive or therapeutic interventions based on their susceptibility to a particular disease or their predicted response to a specific treatment. However, before the use of personalized cancer care can reach its full potential, the health care system must resolve a number of technological, regulatory, and reimbursement issues. To explore these policy challenges, the National Cancer Policy Forum held the workshop Policy Issues in the Development of Personalized Medicine in Oncology in June 2009. Experts provided presentations on the current state of personalized medicine technology, as well as issues in the validation of, regulat

Book information

ISBN: 9780309368575
Publisher: The National Academies Press
Imprint: The National Academies Press
Pub date:
DEWEY: 362.196994
DEWEY edition: 23
Language: English
Number of pages: xx, 85
Weight: 181g
Height: 226mm
Width: 150mm
Spine width: 8mm